Discharge Color in Gonorrhea and Chlamydia
Gonorrhea typically produces purulent (yellow-green) discharge, while chlamydia causes mucopurulent (white to yellow) discharge, though both infections are frequently asymptomatic and discharge characteristics alone cannot reliably distinguish between them.
Gonorrhea Discharge Characteristics
- Gonorrhea causes purulent discharge that is typically thick and yellow-green in color, particularly in symptomatic men with urethritis 1
- Men with gonorrhea commonly present with penile discharge and dysuria, though the discharge is often more profuse and purulent compared to chlamydia 1
- Women with gonorrhea may present with mucopurulent discharge, though many remain asymptomatic 1
Chlamydia Discharge Characteristics
- Chlamydia produces mucopurulent discharge that ranges from white to yellow in color 2, 3
- Mucopurulent cervicitis (MPC) is characterized by a yellow endocervical exudate visible in the endocervical canal or on swab specimens 2, 4
- Women with chlamydial infections may experience abnormal vaginal discharge, though symptoms are often absent or mild 3
- In men, chlamydial urethritis causes urethral discharge that is typically less profuse than gonorrhea, with symptoms often being mild or absent 5
Critical Clinical Pitfalls
- Discharge characteristics are unreliable for diagnosis - both infections frequently present asymptomatically, and when discharge is present, there is substantial overlap in appearance 2, 3
- The absence of discharge does not exclude infection - asymptomatic infection is common in both men and women with either pathogen 6, 3
- Most women with chlamydia or gonorrhea do not have mucopurulent cervicitis - MPC is not a sensitive predictor of infection 2, 4
- Many women with tubal-factor infertility from chlamydia never had symptoms severe enough to prompt treatment 5
Diagnostic Approach
- Never rely on discharge color alone for diagnosis - specific testing with nucleic acid amplification tests (NAATs) is required for both infections 6, 7
- Test for both gonorrhea and chlamydia simultaneously, as coinfection rates are high (20-40% in some populations) 4, 8
- In symptomatic patients with discharge, empiric treatment for both infections should be initiated while awaiting test results if follow-up is uncertain 2, 6
- Testing should be performed on cervical, urethral, or urine specimens using NAATs, which have superior sensitivity compared to culture 6, 7
Treatment Implications
- Dual therapy is essential - patients treated for gonorrhea must also receive treatment effective against chlamydia due to high coinfection rates 4, 8
- Failure to treat concurrent chlamydia in patients with gonorrhea results in 83% microbiological failure for chlamydia 8
- Current first-line treatment is ceftriaxone 250 mg IM for gonorrhea plus azithromycin or doxycycline for chlamydia 1, 9